Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
Stephen L HauserLudwig KapposDouglas L ArnoldAmit Bar-OrBruno BrochetRobert T NaismithAnthony L TraboulseeJerry S WolinskyShibeshih BelachewHarold KoendgenVictoria LevesqueMarianna ManfriniFabian ModelStanislas HubeauxLahar MehtaXavier MontalbanPublished in: Neurology (2020)
NCT01247324/NCT01412333.